Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Neurology
|
December 13, 2007
Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
M Etemadifar, M Janghorbani, V Shaygannejad
Acta Neurologica Scandinavica
|
April 25, 2006
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis
M Etemadifar, M Janghorbani, V Shaygannejad
Acta Neurologica Scandinavica
|
August 21, 2008
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis
F Ashtari, V Shaygannejad, M Akbari
Neurologia
|
September 2, 2022
The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis
O Mirmosayyeb, V Shaygannejad, N Ebrahimi, et al.
Neurologia
|
August 13, 2022
The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis
V Shaygannejad, O Mirmosayyeb, S Vaheb, et al.
Revue Neurologique
|
January 19, 2023
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
O Mirmosayyeb, E M Ghaffary, S Vaheb, et al.
Multiple Sclerosis and Related Disorders
|
May 7, 2018
Phase sensitive reconstruction of T1-weighted inversion recovery in the evaluation of the cervical cord lesions in Multiple Sclerosis; is it similarly eligible in 1.5 T magnet fields?
A Shayganfar, A H Sarrami, S Fathi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 6, 2007
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study
A H Maghzi, M Etemadifar, V Shaygannejad, et al.
Journal of Neurology
|
January 13, 2019
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
V Shaygannejad, E Fayyazi, S Badihian, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 19, 2018
Decreased serum levels of interleukin-35 among multiple sclerosis patients may be related to disease progression
S Badihian, V Shaygannejad, P Soleimani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Neurology
|
December 13, 2007
Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
M Etemadifar, M Janghorbani, V Shaygannejad
Acta Neurologica Scandinavica
|
April 25, 2006
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis
M Etemadifar, M Janghorbani, V Shaygannejad
Acta Neurologica Scandinavica
|
August 21, 2008
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis
F Ashtari, V Shaygannejad, M Akbari
Neurologia
|
September 2, 2022
The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis
O Mirmosayyeb, V Shaygannejad, N Ebrahimi, et al.
Neurologia
|
August 13, 2022
The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis
V Shaygannejad, O Mirmosayyeb, S Vaheb, et al.
Revue Neurologique
|
January 19, 2023
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
O Mirmosayyeb, E M Ghaffary, S Vaheb, et al.
Multiple Sclerosis and Related Disorders
|
May 7, 2018
Phase sensitive reconstruction of T1-weighted inversion recovery in the evaluation of the cervical cord lesions in Multiple Sclerosis; is it similarly eligible in 1.5 T magnet fields?
A Shayganfar, A H Sarrami, S Fathi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 6, 2007
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study
A H Maghzi, M Etemadifar, V Shaygannejad, et al.
Journal of Neurology
|
January 13, 2019
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
V Shaygannejad, E Fayyazi, S Badihian, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 19, 2018
Decreased serum levels of interleukin-35 among multiple sclerosis patients may be related to disease progression
S Badihian, V Shaygannejad, P Soleimani, et al.
Page
of 2